(Q28202285)

2

0 references

L Lespagnard

3

0 references

D Larsimont

4

0 references

M Paesmans

5

0 references

J J Body

Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases

6

0 references

language of work or name

English

0 references

publication date

10 August 2001

0 references

published in

Cancer Letters

0 references

volume

169

0 references

page(s)

87-95

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Cell biology of the osteoclast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Production and regulation of interleukin-11 by breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Interleukin-6 positive follicular hyperplasia in the lymph node of a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Immunocytochemical localisation of interleukin-1 alpha and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Detection of specific mRNAs in routinely processed dermatopathology specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Clinical course and prognostic factors following bone recurrence from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Interleukin-11 inhibits bone formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

The cellular actions of interleukin-11 on bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Protein production by osteoblasts: modulation by breast cancer cell-derived factors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900524-9

7 January 2021

10.1016/S0304-3835(01)00524-9

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2845080

2845080

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference